Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014)
Bio-Techne (TECH) posted quarterly Amortization - Intangibles of $5.7 million for Q3 2014, up 161.79% year-over-year from $2.2 million in Q3 2013, and up 161.79% quarter-over-quarter from $2.2 million in Q3 2013.
Analysis
Bio-Techne (TECH) Amortization - Intangibles (2009 - 2014) Analysis & Trends
Bio-Techne's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $5.7 million for Q3 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2014 | 5.73 Mn |
| Sep 30, 2013 | 2.19 Mn |
| Mar 31, 2011 | 170,000.00 |
| Dec 31, 2010 | 171,000.00 |
| Sep 30, 2010 | 170,000.00 |
| Mar 31, 2010 | 240,000.00 |
| Dec 31, 2009 | 240,000.00 |
| Sep 30, 2009 | 240,000.00 |